Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: Pooled analysis of risperidone effects in children with subaverage IQ

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 2, 2005, Pages 220-232

  Aman, Michael ^a   Buitelaar, Jan ^b   De Smedt, Goedele ^c   Wapenaar, Robert ^c   Binder, Carin ^d  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d Janssen Ortho Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ARTICLE; BEHAVIOR DISORDER; CHILD; DISRUPTIVE BEHAVIOR DISORDER; DRUG EFFECT; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; PROBLEM SOLVING; RATING SCALE; SOCIOLOGY;

ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; MALE; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE;

EID: 19544368807     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.220     Document Type: Article

References (16)

1. Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL, and the Risperidone Disruptive Behavior Study Group: Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 159:1337-1346, 2002.
2. Aman MG, Tassé MJ, Rojahn J, Hammer D: The Nisonger CBRF: A child behavior rating form for children with developmental disabilities. Res Dev Disabil 17:41-57, 1996.
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR). Washington (DC), American Psychiatric Association, 2000.
4. Bauermeister JJ, Canino G, Bird H: Epidemiology of disruptive behavior disorders. Child Adolesc Psychiatr Clin North Am 3:177-194, 1994.
5. Buitelaar JK: Epidemiological aspects: What have we learned over the last decade? In: Hyperactivity and Attention Disorders of Childhood, 2nd edition. Edited by Sandberg S. Cambridge: Cambridge University Press, pp. 30-63.
6. Connor DF, Steingard RJ: A clinical approach to the pharmacology of aggression in children and adolescents. Ann N Y Acad Sci 794:290-307, 1996.
7. Einfeld S, Aman M: Issues in the taxonomy of psychopathology in children and adolescents with mental retardation. J Autism Dev Disord 25:143-167, 1995.
8. Findling RL, Aman MG, Eerdekens M, Derivan A, Lyons B, and the Risperidone Disruptive Behavior Study Group: Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ. Am J Psychiatry 161:677-684, 2004
9. Gadow KD, Sprafkin J: Manual for the Stony Brook Child Symptom Inventory: Parent Checklist. Child Symptom Inventory: Teacher Checklist. Stony Brook (New York), Checkmate Plus, Ltd., 1994.
10. Gillberg C, Persson E, Grufman M, Themner M: Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: Epidemiological aspects. Br J Psychiatry 149:68-74, 1986.
11. Kazdin AE: Practitioner review: Psychosocial treatments for conduct disorder in children. J Child Psychol Psychiatry 38:161-178, 1997.
12. Snyder R, Turgay A, Aman MG, Binder C, Fisman S, Carroll A, The Risperidone Conduct Study Group: Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry 41:1026-1036, 2002.
13. Steiner H: Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. J Am Acad Child Adolesc Psychiatry 36 (Suppl 10):122S-139S, 1997.
14. Sullivan LM, D'Augustino RB, Sr: Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials. Statist Med 22:1317-1334, 2003.
15. Turgay A, Binder C, Snyder R, Fisman S: Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. Pediatrics 110:e34, 2002.
16. World Health Organization: ICD-10. Classification of Mental and Behavioral Disorders. Clinical Description and Diagnostic Guidelines. Geneva, World Health Organization, 1992.